comparemela.com

Latest Breaking News On - Byashley killen - Page 1 : comparemela.com

Chemotherapy-induced peripheral neuropathy common after taxane therapy for breast cancer

Chemotherapy-induced peripheral neuropathy common after taxane therapy for breast cancer
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Itacitinib appears effective for acute graft-versus-host disease

Itacitinib appears effective for acute graft-versus-host disease
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Triplet therapy effective for metastatic prostate cancer subset regardless of disease volume

Treatment intensification with darolutamide plus androgen deprivation therapy and docetaxel improved OS among men with metastatic hormone-sensitive prostate cancer regardless of disease volume or risk, according to study results.The benefits of early treatment intensification appeared consistent among men with high-volume or low-volume disease, as well as those with high-risk or low-risk disease,

Antibiotics during chemotherapy may benefit some patients with pancreatic cancer

Perichemotherapy antibiotics appeared associated with longer survival among patients with metastatic pancreatic ductal adenocarcinoma treated with gemcitabine, according to retrospective study results.Researchers did not observe the same benefit among patients treated with fluorouracil.

Intervention reduces financial toxicity among people with blood cancers

An oncology financial navigation intervention decreased financial toxicity among patients with blood cancers and their caregivers, according to study results.The intervention — called Coverage and Cost-of-Care Links (CC Links) — also received high ratings for acceptability and appropriateness, findings showed.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.